The present and future of lung cancer screening: latest evidence.
Authors
Gutiérrez Alliende J,Kazerooni EA,Crosbie PAJ,Xie X,Sharma A,Reis J
Affiliations (4)
Affiliations (4)
- Medical Affairs for Digital Radiology, Bayer AG, Berlin, Germany.
- Departments of Radiology & Internal Medicine, University of Michigan Medical School, Michigan, MI, USA.
- Division of Immunology, Immunity to Infection & Respiratory Medicine, University of Manchester, Manchester, UK.
- Radiology Department, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract
Lung cancer is the leading cause of cancer-related mortality worldwide. Early lung cancer detection improves lung cancer-related mortality and survival. This report summarizes presentations and panel discussions from a webinar, "The Present and Future of Lung Cancer Screening: Latest Evidence and AI Perspectives." The webinar provided the perspectives of experts from the United States, United Kingdom, and China on evidence-based recommendations and management in lung cancer screening (LCS), barriers, and the role of artificial intelligence (AI). With several countries now incorporating the utilization of AI in their screening programs, AI offers potential solutions to some of the challenges associated with LCS.
Topics
Journal Article